Mira Pharmaceuticals reports positive Phase 1 results for Ketamir-2 trial
PositiveFinancial Markets

Mira Pharmaceuticals has announced promising Phase 1 results for its Ketamir-2 trial, marking a significant step forward in drug development. This trial's success could pave the way for new treatment options, potentially benefiting patients with conditions that Ketamir-2 aims to address. The positive results not only highlight the efficacy of the drug but also reflect the company's commitment to advancing healthcare solutions.
— Curated by the World Pulse Now AI Editorial System